Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (unaudited)

v3.19.3
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 15,717 $ 18,050
Investments 10,657 3,043
Accounts receivable 5
Inventory 771 23
Prepaid expenses and other current assets 537 930
Total current assets 27,682 22,051
Fixed assets, net 1,015 846
Right-of-use assets 1,056
Other non-current assets 13 57
Total assets 29,766 22,954
Current liabilities    
Accounts payable and accrued expenses 2,733 2,140
Operating lease liabilities - current 320
Other current liabilities 494 253
Total current liabilities 3,547 2,393
Contingent royalty obligation 1,885 1,953
Operating lease liabilities - non-current 748
Other non-current liabilities 91
Total liabilities 6,180 4,437
Shareholders' equity    
Preferred stock
Common Stock $0.0001 par value; 50,000,000 shares authorized; 28,796,017 and 21,440,148 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 3 2
Additional paid-in capital 102,110 79,893
Accumulated deficit (78,527) (61,378)
Total shareholders' equity 23,586 18,517
Total liabilities and shareholders' equity 29,766 22,954
Preferred Series A stock [Member]    
Shareholders' equity    
Preferred stock